Candel Therapeutics, Aglatimagene Besadenovec, NSCLC, Non-Small Cell Lung Cancer, Lung Cancer, Phase 2a, Phase 3, AURORA Trial, Immunotherapy,

NEEDHAM, Mass. — October 1, 2026 Candel Therapeutics announced the publication of final Phase 2a clinical trial results evaluating...